This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Petra May: Innovator in LDL Receptor Signaling
Introduction
Petra May is a distinguished inventor based in Dallas, TX (US). She has made significant contributions to the field of biochemistry, particularly in the area of LDL receptor signaling. Her innovative work has led to the development of a patented method that enhances our understanding of cellular signaling mechanisms.
Latest Patents
Petra May holds a patent for LDL receptor signaling assays. This invention provides methods and compositions for modeling and detecting LDL receptor transmembrane signaling by detecting proteolysis of an LDL receptor transmembrane domain. The method comprises several steps: first, providing a sample that includes a cell membrane with a polypeptide comprising an LDL receptor transmembrane domain fused to a C-terminal tail, along with a protease that specifically cleaves the domain. Next, the sample is incubated under conditions that allow the protease to cleave the domain, releasing the tail from the membrane. Finally, the resultant released tail is detected, providing valuable insights into LDL receptor function.
Career Highlights
Petra May is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has garnered attention for its potential applications in understanding cholesterol metabolism and related diseases.
Collaborations
Petra collaborates with Joachim Herz, a fellow researcher, to further explore the implications of her patented methods in the field of biochemistry.
Conclusion
Petra May's innovative contributions to LDL receptor signaling represent a significant advancement in biochemistry. Her patented methods not only enhance our understanding of cellular processes but also pave the way for future research in related health issues.